# Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

> **NCT04929535** · PHASE2 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 51 (estimated)

## Conditions studied

- Basal Cell Carcinoma
- Squamous Cell Carcinoma of Skin Differentiated

## Interventions

- **DRUG:** Hydrogen Peroxide 30 % Topical Solution

## Key facts

- **NCT ID:** NCT04929535
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2023-08
- **Final completion:** 2023-12
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929535, "Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04929535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*